Cargando…
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial
OBJECTIVES: To determine clinical utility of Onclarity human papillomavirus (HPV) assay for atypical squamous cells-undetermined significance (ASC-US) triage, and the value of HPV genotyping within ASC-US. METHODS: Women (n = 33,858; 21 years or older) had HPV testing using Onclarity and Hybrid Capt...
Autores principales: | Wright, Thomas C, Stoler, Mark H, Parvu, Valentin, Yanson, Karen, Eckert, Karen, Kodsi, Salma, Cooper, Charles K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287654/ https://www.ncbi.nlm.nih.gov/pubmed/30189049 http://dx.doi.org/10.1093/ajcp/aqy084 |
Ejemplares similares
-
HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
por: Stoler, Mark H, et al.
Publicado: (2019) -
Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus
por: Young, Stephen, et al.
Publicado: (2020) -
Evaluation of the Becton Dickinson Rapid Influenza Diagnostic Tests in Outpatients in Germany during Seven Influenza Seasons
por: Eggers, Maren, et al.
Publicado: (2015) -
Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013–2014
por: Ndegwa, Linus K., et al.
Publicado: (2017) -
Performance Evaluation of the Becton Dickinson FACSPresto(™) Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa
por: Coetzee, Lindi-Marie, et al.
Publicado: (2016)